EFFECTS OF SINGLE AND COMBINED APPLICATION OF ANTICANCER DRUGS ON CERVICAL ADENOCARCINOMA .1. ANTITUMOR-ACTIVITY IN-VITRO

被引:7
作者
HARA, K [1 ]
IWASAKA, T [1 ]
MATSUO, N [1 ]
NAKAO, Y [1 ]
YOKOYAMA, M [1 ]
YAMASAKI, F [1 ]
MVULA, M [1 ]
SUGIMORI, H [1 ]
机构
[1] SAGA MED SCH,DEPT OBSTET & GYNECOL,NABESHIMA,SAGA 849,JAPAN
关键词
ADENOCARCINOMA; CERVICAL CARCINOMA; COMBINATION CHEMOTHERAPY; INTERFERON-GAMMA; IN VITRO;
D O I
10.3109/00016349509024423
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background. Establishment of effective combination chemotherapy regimen for patients with an adenocarcinoma of the uterine cervix has been long-awaited because there has been no documentation concerning chemosensitivity of this tumor against conventional antitumor agents. Methods. To search for an effective combination regimen, 15 conventional antitumor drugs were tested for growth inhibitory effects on five different cervical adenocarcinoma cell lines. Results. Etoposide, mitomycin C, adriamycin, epirubicin, and vinblastine, were singularly effective. Effects of combination chemotherapy were also tested using the above five antitumor agents plus interferon-gamma. Etoposide, mitomycin C, and interferon-gamma were the most effective when given in combination. Conclusions. Combined treatment with the above three drugs seems worthy of consideration for clinical application.
引用
收藏
页码:330 / 335
页数:6
相关论文
共 30 条
[1]  
BEREK JS, 1985, OBSTET GYNECOL, V65, P46
[2]  
BEREK JS, 1981, CANCER-AM CANCER SOC, V48, P2734, DOI 10.1002/1097-0142(19811215)48:12<2734::AID-CNCR2820481230>3.0.CO
[3]  
2-N
[4]   INTERFERON INHIBITS SENDAI VIRUS-INDUCED CELL-FUSION - AN EFFECT ON CELL-MEMBRANE FLUIDITY [J].
CHATTERJEE, S ;
CHEUNG, HC ;
HUNTER, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (03) :835-839
[5]   INCIDENCE AND HISTOPATHOLOGY OF MALIGNANCIES OF FEMALE GENITAL ORGANS IN UNITED-STATES [J].
CRAMER, DW ;
CUTLER, SJ .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1974, 118 (04) :443-460
[6]  
DAVIS JR, 1975, OBSTET GYNECOL, V45, P79
[7]  
FERENCZY A, 1982, PATHOLOGY FEMALE GEN, P200
[8]  
GALLUP DG, 1977, OBSTET GYNECOL, V49, P596
[9]  
GERFAUX J, 1981, CANCER RES, V41, P3629
[10]   ADENOCARCINOMA OF CERVIX - HISTOPATHOLOGIC AND CLINICAL FEATURES [J].
HURT, WG ;
SILVERBERG, SG ;
FRABLE, WJ ;
BELGRAD, R ;
CROOKS, LD .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1977, 129 (03) :304-315